| Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells N Seddiki, B Santner-Nanan, J Martinson, J Zaunders, S Sasson, ... The Journal of experimental medicine 203 (7), 1693-1700, 2006 | 2069 | 2006 |
| Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over‐active CD4+ T‐cell responses in HIV‐positive patients with mycobacterial immune restoration … N Seddiki, SC Sasson, B Santner‐Nanan, M Munier, D van Bockel, S Ip, ... European journal of immunology 39 (2), 391-403, 2009 | 164 | 2009 |
| Increased Plasma Interleukin-7 Level Correlates with Decreased CDl27 and Increased CD132 Extracellular Expression on T Cell Subsets in Patients with HN-1 Infection SC Sasson, JJ Zaunders, G Zanett, EM King, KM Merlin, DE Smith, ... Journal of Infectious Diseases 193 (4), 505-514, 2006 | 152 | 2006 |
| Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis SC Sasson, SM Slevin, VTF Cheung, I Nassiri, A Olsson-Brown, E Fryer, ... Gastroenterology 161 (4), 1229-1244. e9, 2021 | 135 | 2021 |
| Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary … JJ Zaunders, S Ip, ML Munier, DE Kaufmann, K Suzuki, C Brereton, ... Journal of virology 80 (20), 10162-10172, 2006 | 130 | 2006 |
| Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ... Nature Reviews Immunology 22 (6), 387-397, 2022 | 126 | 2022 |
| Local heroes or villains: Tissue-resident memory T cells in human health and disease SC Sasson, CL Gordon, SN Christo, P Klenerman, LK Mackay Cellular & molecular immunology 17 (2), 113-122, 2020 | 97 | 2020 |
| The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy SC Sasson, JJ Zaunders, AD Kelleher Current drug targets 7 (12), 1571-1582, 2006 | 94 | 2006 |
| Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, SR Khan, SC Sasson, ... Nature Communications 14 (1), 1633, 2023 | 85 | 2023 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 77 | 2021 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 77 | 2021 |
| Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way? VTF Cheung, T Gupta, A Olsson-Brown, S Subramanian, SC Sasson, ... British journal of cancer 123 (2), 207-215, 2020 | 67 | 2020 |
| Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk RV Hewavisenti, J Arena, CL Ahlenstiel, SC Sasson Frontiers in Immunology 14, 1112513, 2023 | 58 | 2023 |
| IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers SC Sasson, S Smith, N Seddiki, JJ Zaunders, A Bryant, KK Koelsch, ... Cytokine 50 (1), 58-68, 2010 | 51 | 2010 |
| Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses H Balachandran, C Phetsouphanh, D Agapiou, A Adhikari, C Rodrigo, ... Cell reports 38 (6), 2022 | 50 | 2022 |
| Lymphopenia in sepsis—an acquired immunodeficiency? S Finfer, B Venkatesh, RS Hotchkiss, SC Sasson Immunology and Cell Biology 101 (6), 535-544, 2023 | 43 | 2023 |
| Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in 3 HIV-infected individuals KK Koelsch, TA Rasmussen, WJ Hey-Nguyen, C Pearson, Y Xu, M Bailey, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (3), 328-337, 2017 | 40 | 2017 |
| Unravelling checkpoint inhibitor associated autoimmune diabetes: from bench to bedside L Wu, VHM Tsang, SC Sasson, AM Menzies, MS Carlino, DA Brown, ... Frontiers in Endocrinology 12, 764138, 2021 | 33 | 2021 |
| Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes L Wu, V Tsang, AM Menzies, SC Sasson, MS Carlino, DA Brown, ... Diabetes Care 46 (6), 1292-1299, 2023 | 27 | 2023 |
| Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a … SC Sasson, JJ Zaunders, K Nahar, CML Munier, BP Fairfax, ... Clinical & Experimental Immunology 202 (3), 335-352, 2020 | 22 | 2020 |
Anthony KelleherProfessor and Program Head, Immunovirology and Pathogenesis Program, Kirby Institute, UNSWVerified email at kirby.unsw.edu.au
